Items where authors include "McDonald, F."

Article

Trimble, A., Sampson, B., Underwood, C.G. et al. (5 more authors) (2024) Journal update monthly top five. Emergency Medicine Journal, 41 (5). pp. 333-334. ISSN 1472-0205

Kapadi, A., Price, G., Faivre-Finn, C. et al. (8 more authors) (2024) Feasibility of implementing a rapid-learning methodology to inform radiotherapy treatments: key professional stakeholders’ views. BMJ Oncology, 3 (1). e000226. ISSN 2752-7948

Khan, S., Hatton, N., Tough, D. et al. (12 more authors) (2023) Lung cancer in never smokers (LCINS): development of a UK national research strategy. BJC Reports, 1 (1). 21. ISSN 2731-9377

Diez, P., Hanna, G.G., Aitken, K.L. et al. (18 more authors) (2022) UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy. Clinical Oncology, 34 (5). pp. 288-300. ISSN 0936-6555

Punjabi, A., Barrett, E., Cheng, A. et al. (21 more authors) (2021) Neutrophil–lymphocyte ratio and absolute lymphocyte count as prognostic markers in patients treated with curative-intent radiotherapy for non-small cell lung cancer. Clinical Oncology, 33 (8). e331-e338. ISSN 0936-6555

Haslett, K., Bayman, N., Franks, K. et al. (10 more authors) (2021) Isotoxic intensity modulated radiation therapy in stage III non-small cell lung cancer: a feasibility study. International Journal of Radiation Oncology*Biology*Physics, 109 (5). pp. 1341-1348. ISSN 0360-3016

Evison, M., Barrett, E., Cheng, A. et al. (20 more authors) (2021) Predicting the risk of disease recurrence and death following curative-intent radiotherapy for non-small cell lung cancer: The development and validation of two scoring systems from a large multicentre UK cohort. Clinical Oncology, 33 (3). pp. 145-154. ISSN 0936-6555

Faivre-Finn, C., Fenwick, J.D., Franks, K.N. et al. (11 more authors) (2020) Reduced fractionation in lung cancer patients treated with curative-intent radiotherapy during the COVID-19 pandemic. Clinical Oncology, 32 (8). pp. 481-489. ISSN 0936-6555

Haslett, K., Franks, K., Hanna, G.G. et al. (12 more authors) (2016) Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study. BMJ Open, 6 (4). e010457. e010457-e010457. ISSN 2044-6055

Proceedings Paper

Haslett, K., Ashcroft, L., Bayman, N. et al. (11 more authors) (2018) PO-0752: Isotoxic Intensity Modulated Radiotherapy in stage III NSCLC – A feasibility study. In: Radiotherapy and Oncology. ESTRO 37, 20-24 Apr 2018, Barcelona, Spain. Elsevier , S387-S387.

Hanna, G., McDonald, F., Greystoke, A. et al. (7 more authors) (2017) EP-1228 : UK NCRI CTRad consensus on drug and radiotherapy combination platform studies in NSCLC. In: Radiotherapy and Oncology. ESTRO 36 - European Society for Radiotherapy & Oncology, 05-09 May 2017, Vienna, Austria. Elsevier , S662-S663.